That is a slanderous statement unsupported by anything remotely resembling facts.
You keep bringing up Phylos and Biotech Institute as if they are one and the same, without any proof of any relationship whatsoever. We agree on Biotech, and several well-known breeders, who seem to be on a kind of patent land grab of the cannabis genome. Add CBD Crew, see United States Patent_ 9095554.pdf (608.0 KB).
Not one of them has a proven financial relationship with Phylos. Hortapharm is old old news. They made a bunch of Skunk 1 seeds for GW Pharma, lost their cultivation license in Holland, and shut down. Watson and Clarke haven't worked together in over 10 years.
Like I said, cannabis patents are going to happen, and they should for companies that create innovative new hybrids and processes. What Phylos is trying to prevent is genetic "colonialism" where any Johnny-come-lately with a lawyer can claim to "discover" Haze, or worse, as we've seen in the Biotech utility patents, any strain that produces THC above a certain level, or CBD in a certain range, or extraction methods otherwise known to the rest of us as cannabutter.
If we are going to have any success as a community in preventing this land grab from claiming the decades of common work and discoveries of the community, we have to stop raging blindly at The Man and start using the same tools as our opponents to secure the future of the cannabis genome as an open resource for study, cultivation and use. The fight is on, right now. We need to see our enemies, and our allies, clearly. Peace -b420